Negative chronotropic effect of β-blockade therapy reduces myocardial oxygen expenditure for nonmechanical work

Circulation

Volumn 94, Issue 3, 1996, Pages 340-345

  Yamakawa, Hideyuki ^a   Takeuchi, Motoshi ^a   Takaoka, Hideyuki ^a   Hata, Katsuya ^a   Mori, Masuki ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

energetics; heart failure; heart rate; adrenergic receptor blockade

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OXYGEN; PROPRANOLOL;

ADULT; AGED; ARTICLE; CHRONOTROPISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM PACING; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEART WORK; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL;

EID: 0029814341     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.3.340     Document Type: Article

References (38)

1. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37:1022-1036.
2. Andersson B, Lomsky M, Waagstein F. The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure: a study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol. Eur Heart J. 1993;14:1375-1385.
3. Heilbrunn S, Shah P, Bristow M, Valantine H, Ginsburg R, Fowler M. Increased β-receptor density and improved hemodynamic response to catecholamine Stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 1989;79:483-490.
4. Eichhorn E, Bedotto J, Malloy C, Hatfield B, Deitchman D, Brown M, Willard J, Grayburn P. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure: improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation. 1990;82:473-483.
5. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A, for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;2:1441-1446.
6. Waagstein F, Caidahl K, Wallentin T, Bergh CH, Hjalmarson A. Long-term β-blockade in dilated cardiomyopathy: effects of short-and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation. 1989;80:551-563.
7. Fisher M, Gottlieb S, Plotnick G, Greenberg N, Patten R, Bennett S, Hamilton B. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. J Am Coll Cardiol. 1994;23:943-950.
8. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1994;90:1765-1773.
9. Eichhorn EJ, Heesch CM, Barnett JH, Alvarez LG, Pass SM, Grayburn PA, Hatfield BA, Marcoux LG, Malloy CR. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1994;24:1310-1320.
10. Conn J, Levine T, Olivari M, Garberg V, Lura D, Francis G, Simon A, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
11. Mann D, Cooper G. Neurohumoral activation in congestive heart failure: a double-edged sword? Clin Cardiol. 1989;12:485-490.
12. Bristow M, Port J, Sandoval A, Rasmussen R, Ginsburg R, Feldman A. β-Adrenergic receptor pathways in the failing heart. Heart Failure. 1989;5:77-90.
13. Simonsen S. Pharmacological effects on coronary haemodynamics: a comparative study between atenolol, verapamil, nifedipine and carbocromen. Acta Med Scand. 1981:645:97-104.
14. Stephans J, Hayward R, Ead H, Adams L, Hamer J, Spurrell R. Effects of selective and nonselective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing. Br Heart J. 1978;40:856-863.
15. Haft J. Cardiovascular injury induced by sympathetic catechol-amines. Prog Cardiovasc Dis. 1974;17:73-85.
16. Cruickshank J, Neil-Dwyer G, Degaute J, Hayes Y, Kuurne T, Kytta J, Vincent J, Carruthers M, Shanta P. Reduction of stress/catecholamine-induced cardiac necrosis by β1-selective blockade. Lancet. 1987;1:585-589.
17. Guth B, Heusch G, Seitelberger R, Ross J. Mechanism of beneficial effect of β-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res. 1987;60:738-746.
18. Kjekshus JK. Importance of heart rate determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 1986;57:43F-49F.
19. Miura T, Miyazaki S, Guth B, Indolfi C, Ross J. Heart rate and force-frequency effects on diastolic function of the left ventricle in exercising dogs, Circulation. 1994;89:2361-2368.
20. Suga H. Ventricular energetics. Physiol Rev. 1990;70:247-277.
21. Takaoka H, Takeuchi M, Odake M, Hayashi Y, Hata K, Mori M, Yokoyama M. Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricle. Circulation. 1993;87:59-69.
22. Takeuchi M, Igarashi Y, Tomimoto S, Odake M, Hayashi T, Tsukamoto T, Hata K, Takaoka H, Fukuzaki H. Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation. 1991;83:202-212.
23. 2) and systolic pressure-volume area (PVA) in human hearts. Eur Heart J. 1992;13:85-90.
24. Burkhoff D, van der Velde E, Kass D, Baan J, Maughan W, Sagawa K. Accuracy of volume measurement by conductance catheter in isolated, ejecting canine hearts. Circulation. 1985;72:440-447.
25. Applegate R, Cheng C, Little W. Simultaneous conductance catheter and dimension assessment of left ventricle volume in the intact animal. Circulation. 1990;81:638-648.
26. Ganz W, Tamura K, Marcus HS, Donoso R, Yoshida S, Swan HJC. Measurement of coronary sinus blood flow by the thermodilution in man. Circulation. 1971;44:181-195.
27. Baim DS, Rothman MT, Harrison DC. Simultaneous measurement of coronary venous blood flow and oxygen saturation during transient alternations in myocardial oxygen supply and demand. Am J Cardiol. 1982;49:743-752.
28. Grossman W, Braunwald E, Mann T, McLaurin L, Green L. Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relation. Circulation. 1977;56:845-852.
29. Nozawa T, Yasumura Y, Futaki S, Tanaka N, Igarashi Y, Goto Y, Suga H. Relation between oxygen consumption and pressure-volume area of in situ dog heart. Am J Physiol 1987;253:H31-H40.
30. Namba T, Takaki M, Araki J, Ishioka K, Suga H. Energetics of the negative and positive inotropism of pentobarbitone sodium in the canine left ventricle. Cardiovasc Res. 1994;28:557-564.
31. Hata K, Goto Y, Suga H. External mechanical work during relaxation period does not affect myocardial oxygen consumption. Am J Physiol. 1991;261:H1778-H1784.
32. Kameyama T, Asanoi H, Ahizaka S, Sasayama S. Ventricular load optimization by unloading therapy in patients with heart failure. J Am Coll Cardiol. 1991;17:199-207.
33. Sunagawa K, Maughan WL, Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res. 1985;56;586-595.
34. Haber H, Simek C, Gimple L, Bergin J, Subbiah K, Jayaweera A, Powers E, Feldman M. Why do patients with congestive heart failure tolerate the initiation of β-blocker therapy? Circulation. 1993; 88:1610-1619.
35. Katz A. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med. 1990;322:100-110.
36. Furengott R, Lee KS. High energy phosphates and the force of contraction of cardiac muscle. Circulation. 1961;24:416-428.
37. Katz A. Cellular mechanism in congestive heart. Am J Cardiol. 1988;62:3A-8A.
38. Andersson B, Hamm C, Persson S, Wikstrom G, Sinagra G, Hjalmarson A, Waagstein F. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 1994;23:1397-1404.